The role of the NLRP3 inflammasome in gout
Sarah R Kingsbury1,2, Philip G Conaghan1,2, Michael F McDermott1,21Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine 2NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds Institute of Molecular Medicine, University of Leeds,
Sarah R Kingsbury +2 more
doaj
Die medikamentöse Therapie der juvenilen idiopathischen Arthritis bei Kindern
ZusammenfassungDie Therapie der juvenilen idiopathischen Arthritis erfolgt durch eine Kombination von nichtsteroidalen Antirheumatika, systemischen und/oder intraartikulären Glukokortikoiden, klassischen Basistherapeutika, Immunsupressiva und Biologika ...
G. Horneff
core +1 more source
A systems biology approach to identify key targets in KRAS/BRAF-mutated colorectal cancer
Background KRAS and BRAF mutations are critical oncogenic drivers in colorectal cancer (CRC), with distinct molecular and clinical implications. Methods To uncover genes differentially expressed between these mutations, we compared KRAS G12D- and BRAF ...
Shiva Shiravi +6 more
doaj +1 more source
Canakinumab i rilonacept per al tractament de les síndromes periòdiques associades a la criopirina
Síndromes periòdiques associades a criopirina; Canakinumab; Assaigs clínics; Rilonacept;Cryopyrin-Associates Periodic Syndrome; CAP; Clinical Trial; Síndromes periódicos asociados a criopirina; Ensayos ClínicosLes síndromes periòdiques associades a ...
Comitè d’Avaluació de Medicaments d’Ús Hospitalari (CAMUH)
core
Correction to: Rilonacept (Interleukin‑1 Inhibition) for the Treatment of Pericarditis [PDF]
Wang, Tom Kai Ming, Klein, Allan L.
openaire +1 more source
Rilonacept Reduces Pericarditis Recurrence Risk, Hospitalizations, and ED visits: Outcomes from the RESONANCE Patient Registry [PDF]
RILONACEPT REDUCES PERICARDITIS RECURRENCE RISK, HOSPITALIZATIONS, AND ED VISITS: OUTCOMES FROM THE RESONANCE PATIENT REGISTRYPaul C. Cremer, MD1, Michael S. Garshick, MD2,3, Sushil A.
Ryan, John J. +13 more
core
Pericarditis is the most common cardiac manifestation of systemic lupus erythematosus (SLE), yet optimal management remains poorly defined. Glucocorticoids are frequently used but are associated with toxicity and increased recurrence risk. Interleukin-1 (
Ilan Richter +13 more
core +1 more source
Recurrent Pericarditis in a Rugby Player: Imaging-Guided Therapy. [PDF]
Abuawad A +10 more
europepmc +1 more source
Retraction Note: Real-world data and Mendelian randomization analysis in assessing adverse reactions of rilonacept. [PDF]
Liu L, Chi Z, Zhang Z.
europepmc +1 more source
Cancer Outcomes in Cardiovascular Trials of Inflammation-Targeting Therapeutics: JACC CardioOncology Primer. [PDF]
Yousif LI, Meijers WC, de Boer RA.
europepmc +1 more source

